Riskpilot← Back to searchSign inGet full accessActive Medica Uppsala AB
ABActiveOrg 5569092074Emil Sjögrens Väg 22Medical specialists activities · NACE 8622Est. 20120 employees
Revenue 2024
SEK 1,1M
-6% vs 2023
EBITDA margin
36.8%
-41% vs 2023
Equity ratio
82.8%
Financial strength
Net profit 2024
SEK 327K
-18% vs 2023
| Revenue | SEK 1,1M | -6% |
| EBITDA | SEK 417K | -41% |
| Net profit | SEK 327K | -18% |
| Total assets | SEK 1,9M | +14% |
| Equity | SEK 1,6M | +27% |
| Employees | 0 | — |
Legal name
Active Medica Uppsala AB
Org number
5569092074
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 november 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla läkartjänster därmed förenlig verksamhet.
Address
Emil Sjögrens Väg 22
Email
dr.jonas.forsman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 189 | 754 | 974 | 1 213 | 1 135 |
| Staff expenses | — | — | −111 | −100 | −121 |
| EBITDA | −34 | 422 | 531 | 704 | 417 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −34 | 422 | 531 | 704 | 417 |
| Net financials | — | — | 0 | −1 | −2 |
| Profit before tax | −19 | 447 | 531 | 504 | 415 |
| Tax | −0 | −90 | −112 | −105 | −88 |
| Net profit | −19 | 357 | 419 | 399 | 327 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 65 | 678 | 1 177 | 1 640 | 1 877 |
| Equity | 52 | 409 | 828 | 1 227 | 1 555 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 13 | 269 | 349 | 413 | 322 |
| Total debt | 13 | 269 | 349 | 413 | 322 |
EBITDA margin
36.8%
This company
15.8%
Market median
+133% vs market
20202024
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20202024
Return on equity
21.1%
This company
18.4%
Market median
+15% vs market
20202024
Net profit margin
28.9%
This company
8.1%
Market median
+257% vs market
20202024
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Active Medica Uppsala AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Josef Forsman | Board of Directors | 0 companies |
| Sara Maria Forsman Benhalima | Deputy Board Member | 0 companies |
| Veronica Vågnes Slettebakk | Deputy Board Member | 0 companies |
| Jawad Benhalima | Deputy Board Member | 0 companies |